News | October 21, 2024
Sunbird Bio raises additional US $14 million to advance Alzheimer blood tech test
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
First patient enrolled in the Phase III SOHO-02 trial of investigational agent BAY 2927088 in treatment-naïve patients with advanced NSCLC with HER2-activating mutations
Further strengthens BaseLaunch's global pharma industry partnerships
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
The decision follows authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in May 2022.
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
AstraZeneca also played a critical role in the global response to COVID-19.
Subscribe To Our Newsletter & Stay Updated
